HIF1AN expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.21169979500269E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.09659999999001E-05 |
Normal-vs-Stage2 |
3.48359999957637E-07 |
Normal-vs-Stage3 |
1.27370336500121E-11 |
Normal-vs-Stage4 |
1.78180026288999E-10 |
Stage1-vs-Stage2 |
4.821900E-02 |
Stage1-vs-Stage3 |
3.70889999999902E-05 |
Stage1-vs-Stage4 |
4.225200E-04 |
Stage2-vs-Stage3 |
2.686600E-01 |
Stage2-vs-Stage4 |
3.282800E-01 |
Stage3-vs-Stage4 |
9.247600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.31429978011965E-10 |
Normal-vs-AfricanAmerican |
1.042130E-03 |
Normal-vs-Asian |
4.117800E-01 |
Caucasian-vs-AfricanAmerican |
2.999000E-01 |
Caucasian-vs-Asian |
1.779200E-01 |
AfricanAmerican-vs-Asian |
4.173200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.33699751059658E-11 |
Normal-vs-Female |
6.72810000046375E-07 |
Male-vs-Female |
5.557700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.317800E-03 |
Normal-vs-Age(41-60Yrs) |
9.83969999923673E-08 |
Normal-vs-Age(61-80Yrs) |
2.33109975766865E-10 |
Normal-vs-Age(81-100Yrs) |
1.38840000052376E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.465200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.914600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.537900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.248350E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.493900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.160780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
6.094200E-01 |
Normal-vs-Grade 2 |
1.51849999996401E-06 |
Normal-vs-Grade 3 |
8.8822282862111E-12 |
Normal-vs-Grade 4 |
4.56250037750294E-10 |
Grade 1-vs-Grade 2 |
1.313850E-02 |
Grade 1-vs-Grade 3 |
4.178800E-04 |
Grade 1-vs-Grade 4 |
2.242500E-04 |
Grade 2-vs-Grade 3 |
1.981330E-03 |
Grade 2-vs-Grade 4 |
3.902200E-03 |
Grade 3-vs-Grade 4 |
5.383200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.21840000000007E-05 |
Normal-vs-ccB subtype |
1.71729996889525E-09 |
ccA subtype-vs-ccB subtype |
1.258060E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.81409995306348E-09 |
Normal-vs-N1 |
1.516440E-01 |
N0-vs-N1 |
3.228400E-01 |
|
|